Kazia Therapeutics (KZIA) Receivables - Net (2009 - 2025)

Kazia Therapeutics' Receivables - Net history runs 17 years deep, the most recent figure standing at $207175.2 for Q4 2025.

• Quarterly Receivables - Net rose 229.55% year-over-year to $207175.2 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $207175.2 (up 229.55% YoY) and the FY2025 annual result came in at $62705.5, down 97.56% from the prior year.
• Receivables - Net was $207175.2 for Q4 2025 at Kazia Therapeutics, up from $62705.5 in the prior quarter.
• Across five years, Receivables - Net topped out at $58.5 million in Q4 2021 and bottomed at $62705.5 in Q2 2025.
• A 5-year average of $6.9 million and a median of $1.3 million in 2025 frame the typical range for Receivables - Net.
• Annual changes were most pronounced in 2023 — Receivables - Net surged 3898.04% — and 2025, when it tumbled 97.56%.
• Kazia Therapeutics' Receivables - Net stood at $58.5 million in 2021, then sank by 95.83% to $2.4 million in 2022, then retreated by 0.19% to $2.4 million in 2023, then plunged by 97.42% to $62866.2 in 2024, then soared by 229.55% to $207175.2 in 2025.
• Business Quant data shows KZIA's Receivables - Net at $207175.2 in Q4 2025, $62705.5 in Q2 2025, and $62866.2 in Q4 2024.